Ricardo G. H.
- Country
- Spain
- Department
- Intensive Care medicine
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Evaluation of Pioglitazone and Metformin Hydrochloride in Metabolic Associated Fatty Liver Disease with Prediabetes: A Pharmacogenetic Approach
Data & Insights
Has run more than one trial at 2 of 258 partner sites.
Specializations
Metabolic Health
This investigator specializes in the study of Metabolic Associated Fatty Liver Disease (MAFLD), particularly focusing on its relationship with prediabetes. Their research explores therapeutic interventions for liver fat regression in patients with metabolic conditions.
- Fatty Liver Disease Management
- Metabolic Disease Interventions
- Long-term Therapeutic Outcomes
The investigator utilizes advanced imaging techniques including magnetic resonance imaging (MRI) for non-invasive assessment of liver conditions.
Diagnostic Innovation
Their work incorporates modern diagnostic approaches using non-invasive monitoring techniques to track disease progression and treatment effectiveness in metabolic disorders.
- Advanced Imaging Applications
- Disease Progression Monitoring
- Therapeutic Response Assessment
The investigator's expertise extends to evaluating sustained therapeutic responses over extended periods in metabolic conditions.
Therapeutic Development
The investigator evaluates various therapeutic intervention models for treating metabolic liver conditions, with a focus on achieving sustained disease regression.
- Comparative Treatment Models
- Long-term Disease Management
- Metabolic Health Optimization
Their research aims to identify optimal therapeutic strategies for managing complex metabolic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.